Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-26
DOI
10.1111/ejn.15608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis
- (2020) R Hergesheimer et al. EXPERT OPINION ON PHARMACOTHERAPY
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
- (2019) Ariel Ionescu et al. Cell Death & Disease
- CLINICAL TRIAL HIGHLIGHTS – DYSKINESIA
- (2019) Kevin McFarthing et al. Journal of Parkinsons Disease
- Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
- (2019) Daniel A. Ryskamp et al. Frontiers in Neuroscience
- Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
- (2018) Tom H. Johnston et al. MOVEMENT DISORDERS
- Utility and reliability of non-invasive muscle function tests in high-fat-fed mice
- (2017) Sergio F. Martinez-Huenchullan et al. EXPERIMENTAL PHYSIOLOGY
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- Amyotrophic lateral sclerosis
- (2017) Orla Hardiman et al. Nature Reviews Disease Primers
- Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
- (2015) Sara OLIVÁN et al. EXPERIMENTAL ANIMALS
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- SOD1 aggregation in ALS mice shows simplistic test tube behavior
- (2015) Lisa Lang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
- (2015) Kristoffer Sahlholm et al. PSYCHOPHARMACOLOGY
- Identification of a Misfolded Region in Superoxide Dismutase 1 That Is Exposed in Amyotrophic Lateral Sclerosis
- (2014) Melissa S. Rotunno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyotrophic lateral sclerosis: a long preclinical period?
- (2014) A. Eisen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET
- (2014) Nisha K. Ramakrishnan et al. PSYCHOPHARMACOLOGY
- High-Fat and Ketogenic Diets in Amyotrophic Lateral Sclerosis
- (2013) Sabrina Paganoni et al. JOURNAL OF CHILD NEUROLOGY
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- The changing scene of amyotrophic lateral sclerosis
- (2013) Wim Robberecht et al. NATURE REVIEWS NEUROSCIENCE
- Lack of sigma-1 receptor exacerbates ALS progression in mice
- (2013) T.A. Mavlyutov et al. NEUROSCIENCE
- SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
- (2013) Yoko Ono et al. NEUROSCIENCE LETTERS
- Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis
- (2013) J. C. Dodge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1G93A Mouse Model
- (2012) Daniele Capitanio et al. ANTIOXIDANTS & REDOX SIGNALING
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
- (2012) Renzo Mancuso et al. Neurotherapeutics
- A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
- (2011) Amr Al-Saif et al. ANNALS OF NEUROLOGY
- A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
- (2011) A. Acevedo-Arozena et al. Disease Models & Mechanisms
- Effects of gender in amyotrophic lateral sclerosis
- (2010) Pamela A. McCombe et al. Gender Medicine
- A novel SOD1 splice site mutation associated with familial ALS revealed by SOD activity analysis
- (2010) Anna Birve et al. HUMAN MOLECULAR GENETICS
- The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study
- (2010) T.A. Mavlyutov et al. NEUROSCIENCE
- Current and emerging treatments for amyotrophic lateral sclerosis
- (2010) Zoccolella Neuropsychiatric Disease and Treatment
- Genetics of motor neuron disorders: new insights into pathogenic mechanisms
- (2009) Patrick A. Dion et al. NATURE REVIEWS GENETICS
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways
- (2008) Tomoko Nishimura et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started